Target intelligence / Profile preview

Epithelial chloride secretory pathway

Molecular classification
Ion channel, Transporter, Enzyme, Receptor
01

Overview

The epithelial chloride secretory pathway is a fundamental physiological process that regulates the transport of chloride ions across epithelial tissues, thereby driving the osmotic movement of water (nih.gov, 2013). This pathway is critical for maintaining the hydration and pH of mucosal surfaces in organs such as the lungs, intestines, and pancreas (nih.gov, 2013). The process involves a coordinated sequence of events: chloride enters the cell at the basolateral membrane via the Na+-K+-2Cl- cotransporter (NKCC1), powered by the Na+/K+-ATPase pump, and exits at the apical membrane through specialized channels, most notably the cystic fibrosis transmembrane conductance regulator (CFTR) and calcium-activated chloride channels (CaCCs) like TMEM16A (nih.gov, 2013; researchgate.net, 2013). Dysregulation of this pathway is central to various pathologies; for example, deficient chloride secretion due to CFTR mutations causes cystic fibrosis, while excessive secretion triggered by bacterial enterotoxins leads to life-threatening secretory diarrhea (nih.gov, 2013; unc.edu, 1991). Therapeutic interventions target various components of this pathway, including CFTR modulators for cystic fibrosis, chloride channel activators like lubiprostone for constipation, and inhibitors like crofelemer for diarrhea management (nih.gov, 2013; unc.edu, 1992).

Other names
Epithelial chloride secretionIntestinal chloride secretory pathwayAirway chloride secretory pathwayChloride secretory pathway
02

Mechanism of action

Activation or inhibition of apical chloride channels (CFTR, CaCC), activation of ClC-2 channels, inhibition of basolateral transporters (NKCC1), and modulation of upstream regulatory receptors such as GC-C and P2Y2.

03

Biological functions

Ion transportFluid secretionOsmoregulationMucociliary clearanceHomeostasis
04

Disease associations

Cystic fibrosisSecretory diarrheaChronic idiopathic constipationIrritable bowel syndrome with constipation (IBS-C)Dry eye syndromeCholera
05

Safety considerations

DehydrationElectrolyte imbalanceHypokalemiaHyponatremiaDiarrheaAbdominal pain
06

Interacting drugs

Ivacaftor

9 more in the full profile.

07

Biomarkers

Sweat chloride concentrationNasal potential difference (NPD)Intestinal current measurement (ICM)Stool volumeTransepithelial potential difference

Beyond the preview

Go deeper on Epithelial chloride secretory pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial chloride secretory pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call